Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ananda Krishna Karanam"'
Autor:
Denise Leclair, Katherine M. Waye, Baltazar Gomez-Mancilla, Brian D. Kiluk, Ananda Krishna Karanam, Partha S. Banerjee, Velusamy Shanmuganathan Muthusamy, Suzanne Maahs
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
BackgroundThere is a paucity of literature describing experiences and journey of individuals with cocaine use disorder (CUD) and supporters who care for them. The aim of this study was to understand and document the journey of individuals with curren
Externí odkaz:
https://doaj.org/article/9b61de0da8c64d1db075b0c6a4860695
Autor:
Messoud Ashina, Stewart J. Tepper, Jan Lewis Brandes, Uwe Reuter, Guy P. Boudreau, Mark Weatherall, Andreas R. Gantenbein, David Doležil, Jan Klatt, Andrea Wang, Ananda Krishna Karanam, Sunfa Cheng, Daniel D. Mikol
Publikováno v:
Ashina, M, Tepper, S J, Brandes, J L, Reuter, U, Boudreau, G P, Weatherall, M, Gantenbein, A R, Doležil, D, Klatt, J, Wang, A, Karanam, A K, Cheng, S & Mikol, DD 2022, ' Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed : A subgroup analysis ', Headache, vol. 62, no. 5, pp. 624-633 . https://doi.org/10.1111/head.14313
Objective: To assess the long-term efficacy and safety of erenumab in the subgroup of patients with chronic migraine (CM) in whom prior preventive treatments had failed (TF) (≥1, ≥2, and ≥3 TF medication categories) and never failed (preventive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cb03f34bd795ac369923b79872e5f0e
https://pubmed.ncbi.nlm.nih.gov/35593783
https://pubmed.ncbi.nlm.nih.gov/35593783
Autor:
Stewart J. Tepper, Huma U. Sheikh, Carrie O. Dougherty, Stephanie J. Nahas, Paul K. Winner, Ananda Krishna Karanam, Andrew M. Blumenfeld, Ahmad Abdrabboh, Soeren Rasmussen, Jamie L. Weiss, Jessica Ailani
Publikováno v:
HeadacheREFERENCES. 62(4)
Therapeutic monoclonal antibodies against the calcitonin gene-related peptide (CGRP) receptor or its ligand have changed the landscape of treatment options for migraine. Erenumab is the first and only fully human monoclonal antibody designed to targe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3178bafe8d6b532ef5b17fd5390fdc91
https://pubmed.ncbi.nlm.nih.gov/35137404
https://pubmed.ncbi.nlm.nih.gov/35137404
Autor:
Kyung Won Park, Vorapun Senanarong, Esther Gunaseli M. Ebenezer, Jacqueline C. Dominguez, Irene Looi, Jong Ling Fuh, Shahul Hameed, Oliver Simon, Ananda Krishna Karanam
Publikováno v:
Journal of Alzheimer's Disease Reports
Clinical diagnosis of Alzheimer's disease (AD) is based on symptoms; however, the challenge is to diagnose AD at the preclinical stage with the application of biomarkers and initiate early treatment (still not widely available). Currently, cerebrospi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bdfc9f91640e2c9afc637f2a53b83a6
https://pubmed.ncbi.nlm.nih.gov/32206755
https://pubmed.ncbi.nlm.nih.gov/32206755
Autor:
Encarnita Ampil, Ming-Chyi Pai, Stephen Christopher, Nagaendran Kandiah, Ananda Krishna Karanam, Vorapun Senanarong, Irene Looi, Kyung Won Park
Publikováno v:
Clinical Interventions in Aging
Several studies have demonstrated clinical benefits of sustained cholinesterase inhibition with rivastigmine in Alzheimer's disease (AD) and Parkinson's disease dementia (PDD). Unlike donepezil and galantamine that selectively inhibit acetylcholinest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15dc44919f330f73258d6ad3ff2bb3c2
https://doi.org/10.2147/cia.s129145
https://doi.org/10.2147/cia.s129145